N. Agar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
N. Agar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
J. Hawk
St John’s Institute of Dermatology, St Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, U.K.
1 shared publicationR. Russell-Jones
St John’s Institute of Dermatology, St Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, U.K.
1 shared publicationS. Morris
Middlesex Hospital, 250 Euston Road, London NW1 2PG, U.K.
1 shared publicationS. Whittaker
St John’s Institute of Dermatology, St Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, U.K.
1 shared publication- Sean J. Whittaker
St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, United Kingdom
1 shared publication
Latest Publications
- 17 February 2009
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 160 (3) , 698-703
Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis
The marked photosensitivity associated with chronic actinic dermatitis (CAD) is presumed to be due to a T cell‐mediated response to ultraviolet (UV)‐induced epidermal neoantigens. Photosensitivity is, however, a rare occurrence in cutaneous T‐cell lymphoma (CTCL). We discuss a series of four patients with erythrodermic CTCL who exhibited marked photosensitivity mimicking CAD. Significantly, the tumour cells had a CD8 phenotype in half of these patients. All patients had T‐cell clones in skin and also demonstrated identical peripheral T‐cell clones in blood or lymph node involvement. Sézary cell counts ranged from 6% to 20%, CD4/CD8 ratios from 0·22 to 23·5. Clinical presentation was striking for a marked photosensitive distribution. Monochromator irradiation testing revealed reduced minimal erythema doses throughout UVB and UVA ranges, findings consistent with those seen in CAD. All patients subsequently died from systemic disease. These findings suggest that, rarely, malignant clonal T‐cell populations may recognize a unique UV‐induced neoantigen, resulting in the clinical features of severe photosensitivity mimicking those seen in CAD.
- 17 February 2009
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 160 (3) , 698-703
Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis
The marked photosensitivity associated with chronic actinic dermatitis (CAD) is presumed to be due to a T cell‐mediated response to ultraviolet (UV)‐induced epidermal neoantigens. Photosensitivity is, however, a rare occurrence in cutaneous T‐cell lymphoma (CTCL). We discuss a series of four patients with erythrodermic CTCL who exhibited marked photosensitivity mimicking CAD. Significantly, the tumour cells had a CD8 phenotype in half of these patients. All patients had T‐cell clones in skin and also demonstrated identical peripheral T‐cell clones in blood or lymph node involvement. Sézary cell counts ranged from 6% to 20%, CD4/CD8 ratios from 0·22 to 23·5. Clinical presentation was striking for a marked photosensitive distribution. Monochromator irradiation testing revealed reduced minimal erythema doses throughout UVB and UVA ranges, findings consistent with those seen in CAD. All patients subsequently died from systemic disease. These findings suggest that, rarely, malignant clonal T‐cell populations may recognize a unique UV‐induced neoantigen, resulting in the clinical features of severe photosensitivity mimicking those seen in CAD.
- 1 August 2008
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 159 (5) , 1197-1199
Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report
Folliculotropic mycosis fungoides is associated with a worse prognosis than classical mycosis fungoides (MF), but whether this is due to resistance to skin-directed therapy or to biological differences is unclear. We discuss a case of a patient with folliculotropic MF (stage IIA) who progressed to develop Sézary syndrome (SS), stage IVB, over 6 years. A 40-year-old man presented with pruritic plaques affecting his head and trunk, characterized by follicular plugging. The histology was consistent with folliculotropic MF and T-cell gene analysis studies revealed a T-cell clone in the skin only. His condition gradually deteriorated and 5 years after presentation, T-cell gene analysis studies revealed the presence of a clone in the blood identical with that seen in the skin. His condition progressed with the development of erythrodermic disease and a leukaemic blood picture and he subsequently died of systemic nodal and visceral involvement. We present the first report detailing the stepwise progression of a patient with stage IIA folliculotropic MF to SS. This case demonstrates that MF and SS represent a clinical spectrum of the same disease.
- 1 August 2008
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 159 (5) , 1197-1199
Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report
Folliculotropic mycosis fungoides is associated with a worse prognosis than classical mycosis fungoides (MF), but whether this is due to resistance to skin-directed therapy or to biological differences is unclear. We discuss a case of a patient with folliculotropic MF (stage IIA) who progressed to develop Sézary syndrome (SS), stage IVB, over 6 years. A 40-year-old man presented with pruritic plaques affecting his head and trunk, characterized by follicular plugging. The histology was consistent with folliculotropic MF and T-cell gene analysis studies revealed a T-cell clone in the skin only. His condition gradually deteriorated and 5 years after presentation, T-cell gene analysis studies revealed the presence of a clone in the blood identical with that seen in the skin. His condition progressed with the development of erythrodermic disease and a leukaemic blood picture and he subsequently died of systemic nodal and visceral involvement. We present the first report detailing the stepwise progression of a patient with stage IIA folliculotropic MF to SS. This case demonstrates that MF and SS represent a clinical spectrum of the same disease.